207 related articles for article (PubMed ID: 21185289)
41. AMP-activated protein kinase: a target for drugs both ancient and modern.
Hardie DG; Ross FA; Hawley SA
Chem Biol; 2012 Oct; 19(10):1222-36. PubMed ID: 23102217
[TBL] [Abstract][Full Text] [Related]
42. Spatial control of AMPK signaling at subcellular compartments.
Chauhan AS; Zhuang L; Gan B
Crit Rev Biochem Mol Biol; 2020 Feb; 55(1):17-32. PubMed ID: 32069425
[TBL] [Abstract][Full Text] [Related]
43. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.
Shackelford DB; Shaw RJ
Nat Rev Cancer; 2009 Aug; 9(8):563-75. PubMed ID: 19629071
[TBL] [Abstract][Full Text] [Related]
44. LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway.
Takahashi Y; Serada S; Ohkawara T; Fujimoto M; Hiramatsu K; Ueda Y; Kimura T; Takemori H; Naka T
Biochem Biophys Res Commun; 2021 Jan; 537():93-99. PubMed ID: 33388415
[TBL] [Abstract][Full Text] [Related]
45. Posttranslational regulation of liver kinase B1 in human cancer.
Hu L; Liu M; Tang B; Li Q; Pan BS; Xu C; Lin HK
J Biol Chem; 2023 Apr; 299(4):104570. PubMed ID: 36870679
[TBL] [Abstract][Full Text] [Related]
46. The serine-threonine kinase LKB1 is essential for survival under energetic stress in zebrafish.
van der Velden YU; Wang L; Zevenhoven J; van Rooijen E; van Lohuizen M; Giles RH; Clevers H; Haramis AP
Proc Natl Acad Sci U S A; 2011 Mar; 108(11):4358-63. PubMed ID: 21368212
[TBL] [Abstract][Full Text] [Related]
47. LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective.
Ciccarese F; Zulato E; Indraccolo S
Oxid Med Cell Longev; 2019; 2019():8730816. PubMed ID: 31781355
[TBL] [Abstract][Full Text] [Related]
48. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Lin R; Elf S; Shan C; Kang HB; Ji Q; Zhou L; Hitosugi T; Zhang L; Zhang S; Seo JH; Xie J; Tucker M; Gu TL; Sudderth J; Jiang L; Mitsche M; DeBerardinis RJ; Wu S; Li Y; Mao H; Chen PR; Wang D; Chen GZ; Hurwitz SJ; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Lei Q; Brat DJ; Ye K; Boggon TJ; He C; Kang S; Fan J; Chen J
Nat Cell Biol; 2015 Nov; 17(11):1484-96. PubMed ID: 26479318
[TBL] [Abstract][Full Text] [Related]
49. A novel LKB1 isoform enhances AMPK metabolic activity and displays oncogenic properties.
Dahmani R; Just PA; Delay A; Canal F; Finzi L; Prip-Buus C; Lambert M; Sujobert P; Buchet-Poyau K; Miller E; Cavard C; Marmier S; Terris B; Billaud M; Perret C
Oncogene; 2015 Apr; 34(18):2337-46. PubMed ID: 24998845
[TBL] [Abstract][Full Text] [Related]
50. Targeting AMPK for cancer prevention and treatment.
Li W; Saud SM; Young MR; Chen G; Hua B
Oncotarget; 2015 Apr; 6(10):7365-78. PubMed ID: 25812084
[TBL] [Abstract][Full Text] [Related]
51. TBC1D23 mediates Golgi-specific LKB1 signaling.
Tu Y; Yang Q; Tang M; Gao L; Wang Y; Wang J; Liu Z; Li X; Mao L; Jia RZ; Wang Y; Tang TS; Xu P; Liu Y; Dai L; Jia D
Nat Commun; 2024 Feb; 15(1):1785. PubMed ID: 38413626
[TBL] [Abstract][Full Text] [Related]
52. Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance.
Yamada E; Lee TW; Pessin JE; Bastie CC
Future Med Chem; 2010 Dec; 2(12):1785-96. PubMed ID: 21428801
[TBL] [Abstract][Full Text] [Related]
53. SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model.
Wang Y; Liang Y; Vanhoutte PM
FEBS Lett; 2011 Apr; 585(7):986-94. PubMed ID: 21130086
[TBL] [Abstract][Full Text] [Related]
54. Role of AMPK and its molecular intermediates in subjugating cancer survival mechanism.
Thirupathi A; Chang YZ
Life Sci; 2019 Jun; 227():30-38. PubMed ID: 31002918
[TBL] [Abstract][Full Text] [Related]
55. LKB1 regulates polarity remodeling and adherens junction formation in the Drosophila eye.
Amin N; Khan A; St Johnston D; Tomlinson I; Martin S; Brenman J; McNeill H
Proc Natl Acad Sci U S A; 2009 Jun; 106(22):8941-6. PubMed ID: 19443685
[TBL] [Abstract][Full Text] [Related]
56. Regulation of LKB1/STRAD localization and function by E-cadherin.
Sebbagh M; Santoni MJ; Hall B; Borg JP; Schwartz MA
Curr Biol; 2009 Jan; 19(1):37-42. PubMed ID: 19110428
[TBL] [Abstract][Full Text] [Related]
57. The Par-1/MARK family of protein kinases: from polarity to metabolism.
Hurov J; Piwnica-Worms H
Cell Cycle; 2007 Aug; 6(16):1966-9. PubMed ID: 17721078
[TBL] [Abstract][Full Text] [Related]
58. [Advances of LKB1-AMPK-mTOR Signaling Pathway in Tumor].
Zhang X; Sun L; Zhong D
Zhongguo Fei Ai Za Zhi; 2011 Aug; 14(8):685-8. PubMed ID: 21859551
[No Abstract] [Full Text] [Related]
59. AMP-activated protein kinase and human cancer: cancer metabolism revisited.
Kuhajda FP
Int J Obes (Lond); 2008 Sep; 32 Suppl 4(Suppl 1):S36-41. PubMed ID: 18719597
[TBL] [Abstract][Full Text] [Related]
60. AMPK potentiation by LKB1 isoforms.
Thibert C; Perret C; Billaud M
Oncotarget; 2015 Nov; 6(34):35139-40. PubMed ID: 26486087
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
